Melanocortin 1 Receptor Agonists Reduce Proteinuria

Annika Lindskog, Kerstin Ebefors, Martin Johansson, Bergur Stefansson, Anna Granqvist, Margret Arnadottir, Anna-Lena Berg, Jenny Nystrom, Borje Haraldsson

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Sammanfattning

Membranous nephropathy is one of the most common causes of nephrotic syndrome in adults. Recent reports suggest that treatment with adrenocorticotropic hormone (ACTH) reduces proteinuria, but the mechanism of action is unknown Here, we identified gene expression of the melanocortin receptor MC1R in podocytes, glomerular endothelial cells, mesangial cells, and tubular epithelial cells. Podocytes expressed most MC1R protein, which colocalized with synaptopodin but not with an endothelial-specific lectin. We treated rats with passive Heymann nephritis (PHN) with MS05, a specific MC1R agonist, which significantly reduced proteinuria compared with untreated PHN rats (P < 0.01). Furthermore, treatment with MC1R agonists improved podocyte morphology and reduced oxidative stress. In summary, podocytes express MC1R, and MC1R agonism reduces proteinuria, improves glomerular morphology, and reduces oxidative stress in nephrotic rats with PHN. These data may explain the proteinuria-reducing effects of ACTH observed in patients with membranous nephropathy, and MC1R agonists may provide a new therapeutic option for these patients.
Originalspråkengelska
Sidor (från-till)1290-1298
TidskriftJournal of the American Society of Nephrology
Volym21
Nummer8
DOI
StatusPublished - 2010

Ämnesklassifikation (UKÄ)

  • Urologi och njurmedicin

Fingeravtryck

Utforska forskningsämnen för ”Melanocortin 1 Receptor Agonists Reduce Proteinuria”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här